VIKING GLOBAL INVESTORS LP - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 300 filers reported holding INTELLIA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.1%.

Quarter-by-quarter ownership
VIKING GLOBAL INVESTORS LP ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$58,496,942
-17.1%
1,569,545
-22.4%
0.28%
-22.1%
Q4 2022$70,526,995
-33.3%
2,021,410
+7.0%
0.35%
-27.7%
Q3 2022$105,712,000
-8.3%
1,889,067
-15.2%
0.49%
-7.6%
Q2 2022$115,341,000
-35.7%
2,228,383
-9.7%
0.53%
-27.2%
Q1 2022$179,405,000
-3.9%
2,468,760
+56.3%
0.72%
+34.8%
Q4 2021$186,764,000
+8.8%
1,579,536
+23.4%
0.54%
+14.2%
Q3 2021$171,649,000
+8.7%
1,279,531
+31.2%
0.47%
-1.7%
Q2 2021$157,877,000975,0920.48%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,113,376$89,359,00015.01%
Burrage Capital Management LLC 63,634$5,107,0004.14%
Integral Health Asset Management, LLC 170,000$13,643,0003.90%
Ally Bridge Group (NY) LLC 225,000$18,057,0003.46%
Elmwood Wealth Management, Inc. 67,174$5,391,0003.29%
Nikko Asset Management Americas, Inc. 4,843,270$388,697,0001.90%
ARK Investment Management 9,611,911$771,404,0001.53%
Spectrum Planning & Advisory Services Inc. 18,521$1,486,0001.53%
Lombard Odier Asset Management (Switzerland) SA 282,953$22,708,0001.51%
Intellectus Partners, LLC 71,625$4,606,0001.26%
View complete list of INTELLIA THERAPEUTICS INC shareholders